New Drug Applications Gilead Receives Complete Response Letter From U.S. FDA for Investigational Lenacapavir Due to Vial Compatibility Issues 3 years ago
New Drug Applications Nymox Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate 3 years ago
New Drug Applications Phathom Pharmaceuticals Submits Vonoprazan NDA to FDA for the Treatment of Erosive Esophagitis 3 years ago
Healthcare News COVID-19 Patients At Greater Risk Of Developing Diabetes, Cardiometabolic Conditions Within A Year 3 years ago
Pharma Industry News Merck’s Keytruda receives FDA approval for advanced endometrial cancer 3 years ago